GDDIF Congress: Global Discovery to Development Innovation Leaders Summit 7th & 8th March 2011.
You have several reasons to come and visit us during GDDIF Congress (7th & 8th of March) in London:
- new strategies on preclinical development and discovery will be discussed.
- to assist to a conference on " In vivo models to select your leads " performed by Vincent Girod, Head of In vivo pharmacology in Syncrosome the 7th of March at 11:15 on the main room. Relevance of in v...
You'll find Syncrosome last publication in the Gastrointestinal field: "Inflence of tachykinin NK2 receptors on intestinal sensitivity and motility in newborn rats" (pdf)
Syncrosome download section:
Nota bene : depending on whether
you are identified or not, you have access to a more or less rich content !
Download our booklets:
SYNCROSOME: Preclinical presentation
CARDIOVASCULAR: models efficacy and safety assessment
NEURODEGENRATIVE DISORDERS: Central nervous system models
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com